Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer
Key facts
- Where
- Turku, FinnországSee the site
- Phase
- 2. fázis
Where in Finnország
- Turku University HospitalTurku, FinnországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Turku University Hospital
- Trial code
- EU 2024-510651-35-00
- Record updated
- 2024. augusztus 20.
- Original description
To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patients with primary colon cancerRead full original descriptionShow less
To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patients with primary colon cancer
Inclusion: Patients with primary colon cancer with suspicion of mesenteric lymph node metastases in computed tomography before primary cancer operation; Patients with primary colon cancer with potentially curable metastases; Patients with suspected metastasis or local recurrence in computed tomography and/or elevated carcinoembryonic antigen (CEA) in cancer surveillance; WHO performance score 0-2; Patient signs informed consent form after receiving written information.
Exclusion: Medical conditions prohibiting whole body PET-CT; Vulnerable study subjects such as described in Finnish law clinical studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be included; Patient is not able to understand purpose of study.